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This study investigated the effects of a recombinant adenovirus, AdR-siPTEN, on learning capability, 
memory and extracellular signal-regulated kinase (ERK) expression in the hippocampus of rats with 
vascular dementia (VD). VD was introduced via permanent bilateral common carotid artery ligation (2-
VO) in rats. AdR-siPTEN recombinant adenovirus and unrelated control adenovirus AdRFP were 
independently injected into the hippocampus of VD rats. Four weeks later, Morris water maze test was 
performed to detect the cognition of rats. Hematoxylin and eosin (HE) and Nissl staining were used to 
observe cellular morphous and neuronal damage in the hippocampus CA1 region. The mRNA and 
protein expression of a phosphatase and tensin homolog deleted on chromosome 10 (PTEN), 
phosphatidylinositol 3-kinase (PI3K), ERK and cAMP response element-binding (CREB) were detected 
by reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry, respectively. 
PTEN expression was reduced apparently in hippocampus after RNAi intervation in the AdR-siPTEN 
group (P<0.05). Compared with the AdRFP group, rats in the AdR-siPTEN group had significantly 
shorter escape latency to the invisible platform (except on the first day of test) (P<0.05); and more 
neurons with regular shape and/or Nissl bodies in hippocampus were observed in the AdR-siPTEN 
group, suggesting attenuated neuronal damage and degeneration. Additionally, the expression of PI3K, 
ERK and CREB in hippocampus CA1 region of AdR-siPTEN treatment group was markedly higher than 
that in the AdRFP group (P < 0.05). However, compared with the normal group, the expression of PI3K, 
ERK and CREB was dramatically decreased in the AdRFP group (P < 0.05). AdR-siPTEN may improve 
the cognition of VD rats, attenuate neuronal damage and promote expression of ERK and CREB, 
leading to the protective effects on neuronal synaptic plasticity in VD rats. These results suggest that 
PTEN down-regulation may exert potential therapeutic effects on VD. 
 






The incidence of aging-related diseases such as arterio-
sclerosis, hypertension as well as various types of dementia 
is increasing with the increase in elderly population 
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second most common form of dementia after Alzheimer 
disease (AD) and refers to a step-wise deterioration in 
cognitive impairment caused by loss of blood supply as a 
result of ischemic or hemorrhagic cerebrovascular 
disease or hypoxia (Kalaria et al., 2004). Following the 
reduction of cerebral blood flow, abnormal energy meta-
bolism occurs after chronic cerebral ischemia which may 
cause neuron injury in vulnerable regions of the brain, 
especially   in   the   hippocampus,  resulting  in  cognitive  




impairment (Zarow et al., 2005). The tumor suppressor 
PTEN (phosphatase and tensin homolog deleted on 
chromosome 10), located on 10q23.3, encodes a 403-
residue dual-specificity phosphatase and was identified in 
1997 as the relevant gene in a region of chromosome 10 
that is often absent in late-stage human tumors, especially 
those of brain (Li et al., 1997). PTEN has both lipid and 
protein phosphatase activity, and has been shown to be 
involved in the regulation of serine, threonine and 
tyrosine phosphorylation (Sarah et al., 2008), and widely 
distributed in the cerebral cortex, cerebellum, olfactory 
bulb and hippocampus (Chol et al., 2005). As a central 
negative regulator of phosphatidylinositol 3-kinase (PI3K) 
pathway involve in cell growth, proliferation and survival, 
PTEN has been found to regulate the development of 
neuron and synapse and subsequent synaptic function 
(Fraser et al., 2008). The extracellular signal-regulated 
kinase (ERK) is one of the most important members of 
the mitogen-activated protein kinase (MAPK) superfamily. 
ERK signaling pathway plays an important role in 
transmitting extracellular signals from cell surface to 
nucleus, and is involve in cell proliferation and diffe-
rentiation. Recently, increasing evidence has shown that 
ERK signaling pathway is closely associated with learning 
and memory (Sheng et al., 2010). It is very well known 
that impairment in learning and memory is one important 
manifestations of VD. In addition, it has been demon-
strated that the phosphatase activity of PTEN can inhibit 
the activation of MAPK through several pathways (Sarah 
et al., 2008), which is closely related to the cognitive 
function of dementia. In the present study, the effects of 
PTEN down-regulation on ERK expression, learning and 
memory in VD rats were investigated to explore the 








A total of 30 healthy adult male Sprague-Dawley rats (specific 
pathogen free) weighing 250 ± 20 g were obtained from the 
Experimental Animal Center of Chongqiong Medical University, 
China. Animals were randomly divided into 3 groups (n = 10 per 
group): Normal, AdR-siPTEN and AdRFP group. In the AdR-
siPTEN group, a recombinant adenovirus with PTEN siRNA, that 
was a 17-nucleotide PTEN target sequence  (5'- AGCTAAAGG 
TGAAGATA-3') corresponding to nucleotides 1687-1703 of PTEN 
mRNA was selected for constructing siPTEN-red fluorescent protein 
(RFP) recombinant adenovirus that mediates the expression of 
PTEN. In the AdRFP group, a scrambled PTEN target sequence 
was designed to construct the control AdRFP recombinant adenovirus. 
The study was carried out after approval by the ethics committee of 




Preparation of the VD model   
 





ligation (2-VO). Adult male SD rats were anesthetized with 3.5% 
chloral hydrate (1 ml/g, intraperitoneally) and fixed in a supine 
position on a frog board. The hair in the middle neck was removed 
followed by sterilization with alcohol and a middle line incision of the 
neck was made. Bilateral common carotid arteries were then 
carefully separated and permanently ligated with 1-0 suture. Finally, 
the wound was closed (Pappas et al., 1996).   
 
 
AdR-siPTEN treatment   
 
Normal rats were fixed in a stereotaxic apparatus (USA), and 5 l of 
recombinant adenovirus, AdR-siPTEN, was slowly injected into the 
hippocampal CA1 region (3.5 mm anterior to the bregma, 1.6 mm 
lateral to the middle line, 3.0 mm subdural) with a microsyringe. 
Seven days later, the rats were decapitated and brains were cut 
into sections. The red fluorescence in the hippocampus was located 
to determine whether the recombinant adenoviruses were accurately 
injected into hippocampus. Two days after injection with the 
recombinant adenovirus, AdR-siPTEN, VD was introduced according to 
the protocols aforementioned.  
 
 
Behavioral test    
 
Four weeks after surgery, the spatial learning performance of rats in 
each group was evaluated by Morris water maze test (Baldi et al., 
2005). For descriptive data collection, the pool was divided into four 
quadrants: I – IV. Rats were placed into the pools (150 cm in 
diameter and 45 cm in height) and the water temperature was 
maintained at 22±2°C. A transparent platform (12 cm in diameter 
and 21 cm in height) was hidden in one of the quadrants. Each rat 
received four tests daily for 7 consecutive days. From day 1 to 6, 
the constant-bearing navigation test was also performed. The rats 
were placed into water in the order of I – IV quadrants. The escape 
latency (time to reach the platform within 120 s) was recorded to 
evaluate the spatial learning performance. If the rat failed to find the 
hidden platform within 120 s, we guided the rat to the platform 
followed by resting on the platform for 30 s, and the escape latency 
was recorded as 120 s.  
In the present study, the escape latency on the sixth day of morris 
water maze test was used to evaluate the learning and memory of 
rats. After constant-bearing navigation test, the spatial probe test 
was performed to assess the retention of spatial memory on the 
seventh day of morris water maze test. The hidden platform was 
removed and each rat was put at a random starting position in the 
pool. The swimming trace and the number of crossing the position 
where the platform was set within 120 s were used to evaluate the 
cognitive performance (Xiong et al., 2006). 
 
 
Reverse transcription polymerase chain reaction (RT-PCR) 
analysis  
 
The mRNA expression of PTEN, PI3K, cAMP response element-
binding (CREB) and ERK in the hippocampus of each group was 
determined by RT-PCR analysis. Four weeks after surgery, animals 
in each group were killed and hippocampus was quickly removed, 
and immediately frozen with dry ice. Total RNA was extracted with 
Trizol (TIANGEN Biotechnology) according to the manufacturer's 
protocol. After determining the concentration and quality of 
extracted RNA by spectrophotometry and 1% agarose gel electro-
phoresis, RNA was immediately reversely transcribed into cDNA 
(Tian et al., 2007). PCR amplification were carried out in a Master 
cycler gradient PCR instrument (Eppendorf, USA) using a protocol 
consisting of 94°C for 3 min in 1 cycle and denaturation at 94°C for 
30 s, annealing for 30 s, and extension at 72°C for 30 s for a total of 
35 cycles.  The  primers  were  as  follows: PTEN-F: 5’-TTGAAGAC  











CATAACCCACC-3’, PTEN-R: 5’-AGTTCCGCCACTGAACAT -3’, 
with annealing at 60°C to obtain amplified products of 361 bp; 
CREB-F: 5’-TTGCCACATTAGCCCAGGTA-3’, CREB-R: 5’-GTTT 
GGTAAATCGGGGTTGG-3’, with annealing at 62°C to obtain 
amplified products of 390 bp; ERk-F: 5’-TGGCTTTCTGACCGA 
GTATGTG -3’, ERk-R: 5’-CTGTGATGCGCTTGTTTGG -3’, with 
annealing at 62°C to obtain amplified products of 367 bp; PI3K-F: 
5’-GTCAAACCATCAAGGTCTCCG-3’, PI3K-R: 5’-TGAGGGGCG 
TTTCACCTACTA-3’, with annealing at 60°C to give amplified 
products of 173 bp; GAPDH-R: 5’-TCAACGGCACAGTCAAGG-3’, 
GAPDH-F: 5’-ACCAGTGGATGCAGGGAT-3’ with annealing at 
58°C to obtain amplified products of 469 bp. The PCR products 
were electrophoresed with a 1% agarose gel. Images were captured 
and data were analyzed by Quantity one 4.6 software. The mRNA 
levels were calculated as ratios of intensities of specific mRNAs to 





At the end of the behavioral tests, the rats were deeply anae-
sthetized with 3.5% chloral hydrate, and then a catheter was 
intubated to the ascending aorta through the left ventricle. 
Transcardial perfusion with saline was performed followed by ice-
cold 4% paraformaldehyde (400 ml). The brain was removed and 
paraffin-embedded. Coronal and serial sections (4 mm in thickness) 
were taken from each brain (Xiong et al., 2006). Hematoxylin and 
eosin (HE) and Nissl staining were performed in sections from same 
layers of each rat to observe the cellular morphous and neuronal 
damage in the hippocampus CA1 region. Under a light microscope, 
neurons with round- or oval-shaped nuclei and without shrinkage or 
edema were regarded as undamaged.   
 
 
Immunohistochemistry   
 
Animals in each group were sacrificed at 28 days post-surgery for 
immunohistochemistry. Immunostaining was carried out with the 
septum pellucidum (SP) method. The slides were prepared with 
same methods for HE and Nissl staining. For immuno-histo-
chemistry, brain sections were incubated with primary antibody 
overnight at 4°C. The following primary antibodies (ZSGB-Bio) were 
used: rabbit anti-CREB (1:100), and rabbit anti-ERK (1:100). After 
washing with phosphate buffered saline (PBS), sections were 
incubated with corresponding secondary antibodies. Thereafter, 
sections were treated with SP staining kit (Santa Cruz Biotechnology). 
Then, the sections were observed under a light microscope (Olympus, 
Japan) connected to a computer. Representative images were 
obtained and mean density (IOD/area) was analyzed with Image 
Pro Plus 6.0 analysis system (Park et al., 2004). 
 
 
Statistical analysis  
 
Data were expressed as means ± standard deviation (SD). Statistical 
analysis was performed with one-way analysis of variance 
(ANOVA) and multivariate analysis of variance for the repeated 
measures of water maze test. The SPSS 13.0 was used for 




RESULTS   
 
Detection of red fluorescence in hippocampus  
 
Red fluorescence in the hippocampus after injection with 
recombinant adenovirus, AdR-siPTEN, was observed 
under a fluorescent microscope (Olympus, Japan). As 
shown in Figure 1, plenty of red fluorescent proteins were 
observed in the hippocampus demonstrating that the 
recombinant adenoviruses were accurately infected into 
the hippocampus.  
 
 
Morris water maze test   
 
Morris water maze test was used to detect the learning 
and memory ability of rats. As shown in Table 1, the 
escape latency in AdR-siPTEN-treated group was signifi-
cantly shorter than that in the AdRFP control group. 
Compared with  normal  rats,  the  rats  in  AdRFP  group  




Table 1. Escape latency and numbers of crossing over the platform in each group 
( x ±S). 
 
Groups Escape latency(s) Numbers of crossing the platform 
normal 7.837±1.32 6.38±1.41 
siPTEN 12.06±1.58 4.63±0.74 
AdRFP 32.09±3.47* 1.63± 0.74 ## 
 





a. normal b. siPTEN    c. AdRFP  
 










spent more time in finding the platform accompanied by 
prolonged escape latency (P<0.05). However, the pro-
longed latency was significantly reduced in AdR-siPTEN-
treated group compared with AdRFP group. Figure 2 
shows the representative swimming traces of normal and 
siPTEN-treated rats determined by the spatial probe test. 
The traces were localized in the target zone where the 
platform was placed. However, in the AdRFP group, the 
traces were uniformly distributed in four quadrants. In 
addition, the numbers crossing the platform were signifi-
cantly reduced in AdRFP group when compared with 
AdR-siPTEN treated group (P<0.05).  
HE and Nissl staining  
 
Figure 3 shows the representative photos of HE staining. 
Under a light microscope, a lot of cells in pyramidal layers 
were arranged regularly with normal morphology and 
integrated structures. Meanwhile, neuronal injury was 
observed in the hippocampal CA1 area of AdRFP treated 
rats. The cells in pyramidal layers were arranged ire-
gularly, nuclei were shrunk accompanied by cell swelling 
and the number of normal pyramidal cells was significantly 
reduced. On the contrary, the abnormal morphology and 
decreased   number  of  cells  in  hippocampal  CA1  area  












Figure 5. mRNA expression of PTEN, PI3K, CREB and ERK in each group determined by RT-
PCR analysis. mRNA expression of PTEN was weakly in siPTEN group, accompanied with the 
converse changes of PI3K, CREB and ERK, which were weakly in AdRFP group but increased 




were markedly attenuated in siPTEN-treated group, sug-
gesting PTEN down-regulation prevented the neuronal 
injury caused by chronic cerebral ischemia. As shown in 
Figure 4, in the normal group, the Nissl body was obviously 
observed in the Nissl staining. However, a majority of 
neurons in the AdRFP group underwent peripheral 
edema with blue cytoplasm, and the cell body collapsed 
or shrunk. Meanwhile, the Nissl body in the cells formed 
into granules or even vanished. The collapse and shrinkage 
of cell body were dramatically improved in the AdR-
siPTEN-treated group, and more Nissl body was observed, 
indicating improved neuronal damage.  
 
 
mRNA expression of PI3K, CREB and ERK   
 
The mRNA expressions of PTEN, PI3K, CREB and ERK 
in each group were determined by RT-PCR. As shown in 
Figure 5, compared with AdRFP group, the mRNA 
expression   of   PTEN  was  markedly  attenuated  in  the  






Figure 6. Protein expression of ERK and CREB in hippocampus CA1 region of each group determined by 




AdR-siPTEN group (P<0.05). The mRNA expressions of 
these three genes were increased in the AdR-siPTEN 
group accompanied by decrease in PTEN expression. In 
addition, the mRNA expressions of PI3K, CREB and ERK 
in AdRFP group were significantly lower than those in the 
normal roup and AdR-siPTEN group (P<0.05). These 
results indicated that down-regulation of PTEN might be 
involved in and likely contribute to the increased 





Immunohistochemistry showed CREB and ERK positive 
cells in the normal group. The analysis of immuno-
histological findings in the AdR-siPTEN and AdRFP group is 
shown in Figure 6. The positive cells were stained brown-
yellow. The expressions of CREB and ERK were markedly 
increased in normal hippocampus CA1 area. However, 
AdR-siPTEN treatment improved the activation of CREB 
and ERK in the hippocampus and increased the number 
of positive neurons for CREB or ERK, as compared to the 
AdRFP group (P<0.05). Results of image analysis of 
immunohistological findings are shown in Figure 7. The 
mean density of CREB and ERK-positive reaction 
product in AdRFP group was significantly lower than that 
in the normal group, while the AdR-siPTEN treatment 
group had a higher mean density as compared to the 





In the present study, the major findings were that PTEN 
down-regulation significantly elevated the decreased 
expression of PI3K/ERK/CREB (cAMP response element-
binding protein) in the hippcampal lesions. A potent 
protection against neuronal injury caused by chronic 
cerebral ischemia was shown, leading to improvement in 
the neurological dysfunction and symptoms of VD in rats.  
VD is usually thought to be caused by various cere-
brovascular injury and numerous studies have demon-
strated that remains the second common diseases 
among age-related dementia (Yanpallewar et al., 2004; 
Zhao et al., 2005; Borlongan et al., 2005). It has been 
reported that cerebral ischemia can develop cognitive 
deficit and neuronal damage. VD patients are usually 
found to have cerebral ischemia and cognitive deficit in 
clinical trials with large sample size. In the present study, 
the permanent occlusion of bilateral common carotid 
arteries was introduced, which can mimic the VD in 
humans. However, the pathogenesis of VD is very 
complex and still not completely clarified. In recent years, 
increasing studies have shown that changes in synaptic 
plasticity play an important role in the pathogenesis of 
VD. Synaptic damage is  observed  at  the  early  stage of  







Figure 7. Mean density of ERK and CREB in each group. # P < 




VD, and closely associated with cognitive deficit, but the 
exact mechanism is poorly understood. As a negative 
regulator of PI3K pathway, PTEN is involved in the deve-
lopment of neuron and synapse and subsequent synaptic 
function (Fraser et al., 2008). The PI3K/Akt signaling 
pathway can regulate the expression of ERK and CREB, 
which is closely related to the cognitive function in VD 
patients. Our results showed that down-regulation of 
PTEN definitely elevated the decreased expression of 
PI3K/ ERK/CREB in the hippocampus of VD rats, 
participating in the protection of synaptic plasticity.  
The present study focused on the relationship between 
PTEN and PI3K, ERK, CREB in the ischemic brain. 
PTEN is known to negatively regulate several cellular 
functions, including cell cycle progression, cell migration, 
and survival by suppressing PI3K/Akt activation via 
dephosphorylating the phosphatidylinositol (3,4,5)-tripho-
sphate(PIP3) to an inactive state of  phosphatidylinositol 
(4,5)-diphosphate(PIP2). In recent years, studies have 
focused on the relationship between PTEN and cerebral 
ischemia. It has been reported that PTEN plays an impor-
tant role in neuroprotection. Jeong et al. (2004) found that 
cilostazol could ameliorate the neuronal damage by 
down-regulating PTEN phosphorylation with resultant 
increase in the Akt and CREB phosphorylation and Bcl-2 
expression to suppress apoptotic cell death which 
contributed to the improvement in the neurological dete-
rioration. Furthermore, studies have shown that inhibitors 
of PTEN-pic were also involved in the activation of 
PI3K/Akt   signaling   pathway   through   inhibiting  PTEN  
ERK 
CREB 




expression which resulted in the protection of ischemic 
neurons (Xiaohui et al., 2007). Additionally, besides the 
PI3K/Akt signaling pathways, ERK signaling pathway 
also plays an important part in the biological functions of 
PTEN. Studies have indicated that PTEN can inhibit ERK 
activation through its phosphatase activity. Thus, it is 
speculated that PTEN confers regulatory effects through 
ERK signaling pathway. There is a negative correlation 
between PTEN and ERK (Qiuxue et al., 2006). In the 
present study, after infection with recombinant adenovirus 
siPTEN, the PTEN expression in the hippocampus was 
significantly declined accompanied by profoundly increased 
expressions of PI3K /ERK/CREB which further down-
regulated PTEN expression. These results were 
consistent with previous studies.   
The ERK is one of the important members of the MAPK 
superfamily. It has been reported that the ERK signaling 
pathway is involve in cell growth, proliferation and 
differentiation. In recent years, accumulating evidence 
has shown that ERK signaling pathway was closely asso-
ciated with learning and memory (Giovannini, 2006; 
Sweatt, 2004; Ji et al., 2009; Shaywitz and Greenbe, 
1999). A study showed that MEK inhibitor (PD98059) 
could inhibit hippocampal long-term potentiation (LTP), 
which is generally accepted as one of the cellular 
mechanisms involved in learning and memory (Sheng et 
al., 2010). Behavioral studies showed the activation of 
ERK in the hippocampus after water maze training in 
mice. Furthermore, recent investigation also demon-
strated Ras/ERK pathways were involved in human 
cognition. ERK kinase inhibitors could block the sustained 
phosphorylation of CREB residue Ser133 and affect the 
CREB-dependent transcription, suggesting ERK plays a 
role in regulating the CREB activity. That is to say, 
through the regulation of certain nuclear transcription 
factors, such as CREB, ERK plays a regulatory role in the 
LTP, as well as learning and memory. In our study, the 
results of both RT-PCR and immunohistochemistry 
demonstrated the expression of ERK and CREB was 
decreased in the hippocampus CA1 region of VD rats, 
which was obviously reversed in the siPTEN-treated rats 
with VD accompanied by a lower expression of PTEN. 
The results above suggested PTEN down-regulation 
definitely increased the expression of ERK and CREB, 
thereby participating in the neuronal synaptic plasticity 
and the improvement of learning and memory of VD rats. 
There might be several pathways implicated in the 
protective effects of down-regulated PTEN expression. 1) 
As the inhibition of ERK by PTEN through Ras or calcium 
signaling pathway was inhibited after PTEN down-
regulation, the expression and activation of ERK were 
increased accompanied by improvement of learning and 
memory; 2) PTEN down-regulation suppresses apoptotic 
cell death and promotes cell growth via activating 
PI3K/Akt signaling pathway with resultant increase in Akt 
and CREB phosphorylation and increased Bcl-2 expression 





CREB is accepted as a key factor in cell survival and 
involves in regulating regeneration, survival and repair of 
neurons after ischemic injury. Therefore, increased CREB 
activity leads to the protection of learning and memory as 
well as synaptic plasticity. Additionally, the activation of 
ERK can regulate synaptic proteins and promote formation 
of new dendritic spines. Increased ERK level affects the 
phosphorylation of nuclear transcription and translation 
factors related to LTP suggesting synaptic plasticity, and 
plays positive regulatory role in the induction and 
maintenance of LTP, resulting in the improvement of 
learning and memory in VD rats. 
In conclusion, the present study demonstrated that 
PTEN down-regulation via AdR-siPTEN improved the 
cognitive impairment caused by chronic cerebral ischemia, 
attenuated neuronal injury and protected synaptic plasticity. 
These findings provide a new target for the prevention 
and treatment of VD. However, the specific mechanisms 
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VD, Vascular dementia; AD, Alzheimer disease; PTEN, 
phosphatase and tensin homolog deleted on 
chromosome 10; PI3K, phosphatidylinositol 3-kinase; 
ERK, extracellular signal-regulated kinase; MAPK, 
mitogen-activated protein kinase; RT-PCR, reverse 
transcription polymerase chain reaction; RFP, red 
fluorescent protein; CREB, cAMP response element-
binding; GAPDH, glyceraldehyde 3-phosphate 
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